Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Forearm Muscle and Tendon Thickness in Rotator Cuff-Related Shoulder Pain

17 de junio de 2026 actualizado por: Ömer Faruk ÖZÇELEP, Kirsehir Ahi Evran Universitesi

Ultrasonographic Assessment of Forearm Muscle and Tendon Thickness According to Symptom Duration in Individuals With Rotator Cuff-Related Shoulder Pain

Rotator cuff-related shoulder pain (RCRSP) is one of the most common musculoskeletal disorders affecting the shoulder and is frequently associated with pain, reduced muscle strength, and impaired upper extremity function. Although previous studies have primarily focused on structural and functional changes around the shoulder, little is known about the potential adaptations occurring in the distal upper extremity, particularly the forearm muscles and tendons.

Altered upper extremity use, pain-related muscle inhibition, and compensatory movement patterns associated with prolonged shoulder pain may lead to morphological changes in the forearm musculature and tendons. However, the relationship between symptom duration and these structural adaptations has not yet been investigated.

The aim of this cross-sectional study is to evaluate forearm muscle and tendon thickness using portable ultrasonography in individuals with RCRSP and to investigate whether these parameters differ according to symptom duration. In addition, hand grip strength, pain intensity, and upper extremity function will be assessed to explore their associations with ultrasonographic findings.

The findings of this study are expected to provide new insights into distal upper extremity adaptations associated with RCRSP and may contribute to the development of more comprehensive rehabilitation strategies that address not only the shoulder but also the forearm musculature.

Descripción general del estudio

Estado

Aún no reclutando

Descripción detallada

Rotator cuff-related shoulder pain (RCRSP) is one of the leading causes of shoulder pain and disability in adults. In addition to local impairments such as pain, muscle weakness, and reduced range of motion, individuals with RCRSP frequently demonstrate altered upper extremity movement patterns and reduced functional performance. These adaptations may extend beyond the shoulder joint and influence distal segments of the upper extremity.

Previous research has primarily focused on structural changes in the rotator cuff muscles and tendons, scapular musculature, and shoulder biomechanics. However, the potential morphological adaptations of the forearm muscles and tendons remain largely unexplored. Persistent pain, reduced upper limb use, altered neuromuscular control, and compensatory motor strategies associated with prolonged shoulder symptoms may contribute to changes in forearm muscle and tendon morphology. Understanding these adaptations may improve the current understanding of the regional effects of RCRSP.

Musculoskeletal ultrasonography provides a valid, reliable, non-invasive, and accessible method for evaluating muscle and tendon morphology. The increasing availability of portable ultrasound devices has expanded the feasibility of assessing musculoskeletal structures in both clinical and research settings. Despite these advantages, ultrasonographic evaluation of forearm muscles and tendons has rarely been performed in individuals with RCRSP.

This cross-sectional study aims to investigate the association between symptom duration and forearm muscle and tendon thickness measured by portable ultrasonography in individuals with RCRSP. The study also seeks to explore whether structural changes in the forearm are accompanied by alterations in hand grip strength, pain intensity, and upper extremity function. The findings may contribute to a better understanding of distal musculoskeletal adaptations associated with prolonged shoulder pain and provide evidence for incorporating forearm assessment into rehabilitation programs for individuals with RCRSP.

Tipo de estudio

De observación

Inscripción (Estimado)

90

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Método de muestreo

Muestra no probabilística

Población de estudio

### Study Population Description

The study population will consist of adult individuals aged 18-65 years, including both patients with rotator cuff-related shoulder pain (RCRSP) and healthy control participants. Participants with RCRSP will be recruited based on clinical diagnosis confirmed by physical examination and positive clinical tests consistent with rotator cuff-related shoulder pain. Healthy controls will be recruited from the community and hospital staff and will have no history of shoulder pain or upper extremity musculoskeletal disorders.

Patients with RCRSP will be further categorized according to symptom duration into subgroups for comparative analysis. All participants will undergo a single assessment session including ultrasonographic evaluation of forearm muscle and tendon thickness, hand grip strength measurement, and standardized functional and pain assessments.

Participants will be recruited from outpatient physiotherapy and orthopedic clinics of the participatin

Descripción

Inclusion Criteria:

RCRSP Group Adults aged 18-65 years. Clinical diagnosis of rotator cuff-related shoulder pain (RCRSP). Unilateral shoulder pain lasting at least 6 weeks. Pain localized around the anterolateral shoulder, aggravated by arm elevation and/or overhead activities.

Positive findings on at least three clinical tests suggestive of RCRSP (e.g., painful arc, Hawkins-Kennedy test, Neer test, Jobe/Empty Can test, resisted external rotation).

Ability to understand the study procedures and provide written informed consent.

Healthy Control Group Adults aged 18-65 years. No current shoulder pain. No history of shoulder pain, shoulder surgery, or upper extremity musculoskeletal disorders during the previous 12 months.

Ability to provide written informed consent.

Exclusion Criteria:

Previous shoulder surgery on either upper extremity. History of shoulder fracture, shoulder dislocation, or major upper extremity trauma.

Full-thickness rotator cuff tear or other shoulder pathology requiring surgical management.

Clinical signs of adhesive capsulitis. Cervical radiculopathy or other neurological disorders affecting the upper extremity.

Systemic inflammatory, rheumatologic, or neuromuscular diseases. Peripheral nerve entrapment (e.g., carpal tunnel syndrome, cubital tunnel syndrome).

Previous surgery or significant injury involving the forearm, wrist, or hand. Corticosteroid injection into the affected shoulder within the previous 3 months.

Current pregnancy. Inability to complete study assessments or provide informed consent.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Healthy Controls
Healthy individuals without shoulder pain or a history of shoulder pathology, matched to the patient groups by age and sex where possible.
Short-Duration RCRSP
Participants diagnosed with rotator cuff-related shoulder pain with symptom duration of less than 6 months.
Long-Duration RCRSP
Participants diagnosed with rotator cuff-related shoulder pain with symptom duration of 6 months or longer.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Forearm Muscle and Tendon Thickness
Periodo de tiempo: Baseline (single assessment)
Forearm muscle and tendon thickness will be measured using portable B-mode ultrasonography. Measurements will be obtained from standardized anatomical landmarks with participants in a standardized position. The thickness (mm) of selected forearm flexor and extensor muscles and tendons will be recorded and compared between healthy controls and participants with rotator cuff-related shoulder pain according to symptom duration.
Baseline (single assessment)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Hand Grip Strength
Periodo de tiempo: Baseline (single assessment)
Maximum isometric hand grip strength will be assessed using a calibrated hand dynamometer. Three consecutive measurements will be obtained from the affected upper extremity with standardized positioning, and the highest value (kg) will be used for analysis.
Baseline (single assessment)
Upper Extremity Function
Periodo de tiempo: Baseline (single assessment)
Upper extremity disability and symptoms will be evaluated using the Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. Scores range from 0 to 100, with higher scores indicating greater disability.
Baseline (single assessment)
Shoulder Pain Intensity
Periodo de tiempo: Baseline (single assessment)
Shoulder pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain.
Baseline (single assessment)
Symptom Duration
Periodo de tiempo: Baseline
Symptom duration will be recorded in months based on participant self-report and clinical history. Participants with rotator cuff-related shoulder pain will be categorized into groups according to symptom duration for comparative analyses.
Baseline
Shoulder Proprioception
Periodo de tiempo: Baseline
Shoulder joint position sense (JPS) will be assessed using a laser pointer repositioning test. Repositioning error will be recorded in centimeters, with greater deviation indicating poorer proprioceptive accuracy.
Baseline

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

18 de julio de 2026

Finalización primaria (Estimado)

18 de diciembre de 2026

Finalización del estudio (Estimado)

19 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

17 de junio de 2026

Primero enviado que cumplió con los criterios de control de calidad

17 de junio de 2026

Publicado por primera vez (Actual)

23 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

23 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

17 de junio de 2026

Última verificación

1 de junio de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • KAEÜFTR-4

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir